BDBM333237 (2S,3R,4S)-2-(8-(isopentylamino)-[1,2,4]triazolo[4,3-a]pyrazin-3-yl)tetrahydrothiophene-3,4-diol::US10196396, Compound 32

SMILES CC(C)CCNc1nccn2c(nnc12)[C@@H]1SC[C@@H](O)[C@H]1O

InChI Key InChIKey=FMHMTYOHKMEZCH-GMTAPVOTSA-N

Data  1 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 333237   

TargetAdenosine receptor A3(Homo sapiens (Human))
Handok

US Patent
LigandPNGBDBM333237((2S,3R,4S)-2-(8-(isopentylamino)-[1,2,4]triazolo[4...)
Affinity DataKi:  55nMAssay Description:HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Handok

US Patent
LigandPNGBDBM333237((2S,3R,4S)-2-(8-(isopentylamino)-[1,2,4]triazolo[4...)
Affinity DataIC50: <10nMAssay Description:HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent